Projects funded by the NCN
Investigation of a new therapeutic strategy to lower mutant protein in SCA3 / MJD
2021/41/B/NZ2/03881
Keywords:
SCA3 MJD spinocerebellar ataxia 3 ataxin-3 ATXN3 SCA3 mouse knock-in mutant protein PolyQ CAG repeats proteaphagy autophagy proteasome
Descriptors:
- NZ2_1: Molecular genetics
- NZ2_3: Proteomics
- NZ3_5: Molecular neurobiology
Panel:
NZ2 - Genetics, genomics: molecular genetics, genomics, proteomics, bioinformatics, systems biology, genetic epidemiology
Host institution :
Instytut Chemii Bioorganicznej Polskiej Akademii Nauk
woj. wielkopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 5
Call: OPUS 21 - announced on 2021-03-15
Amount awarded: 2 424 140 PLN
Project start date (Y-m-d): 2022-02-01
Project end date (Y-m-d): 2026-01-31
Project duration:: 48 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.